Ethical considerations of using gene therapy for exudative AMD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This qualitative study uses semi-structured interviews with adults treated for exudative AMD at CHU Nantes to explore views on gene therapy. It examines perceived benefits and risks, autonomy in decision-making, and expectations regarding this innovative but irreversible approach. The analysis focuses on patients’ experiences with current injections, concerns about gene therapy, and how information and support influence their choices. The study does not involve testing the therapy itself but rather investigates ethical and patient-centered aspects of its potential use.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with exsudative AMD, male female \>18 years Patients for whom the doctor could consider gene therapy.

Exclusion Criteria:

Patients with atrophic AMD (Age-related Macular Degeneration) Patients with other degenerative retinal diseases than AMD, Patients with with associated cognitive disorders.

Where it's running

• CHU Nantes - Ophthalmology Department
  Nantes, Nantes, France Recruiting

Study contacts

• Study coordinator: Helene Masse, M.D
• Email: helene.masse@chu-nantes.fr
• Phone: +33 2 53 48 28 57

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Switching to aflibercept 8 mg in exudative AMD

  This real-world study looks at whether switching to a higher-dose aflibercept can extend treatment intervals for adults with exudative AMD who previously needed frequent injections.

  Recruiting Nantes University Hospital · Nantes, Nantes · NCT07423429

• Four-session focal shock wave therapy for vulvodynia in women

  This study looks at whether four weekly sessions of low-intensity focal shock wave therapy help women with vulvodynia in real-life clinical practice.

  Recruiting Nantes University Hospital · Nantes, Nantes · NCT07553715

• Reproducibility of Digital Bite Mark Overlays in Adults

  This study tests how consistently different people can create digital bite mark overlays from 3D dental scans in adults who need routine dental care.

  Recruiting Nantes University Hospital · Nantes, Nantes · NCT07552051

• Dental care for people living with HIV in Pays de la Loire

  This study looks at whether people living with HIV in Pays de la Loire need any special dental management based on their health data.

  Recruiting Nantes University Hospital · Nantes, Nantes · NCT07552038

• 68Ga-FAPI-46 PET imaging to stage ATTR-CM and spot progression

  This study tests whether a gallium-68 labeled FAPI PET scan can help stage transthyretin cardiac amyloidosis and identify patients whose disease is progressing.

  Recruiting Phase 2 Nantes University Hospital · Nantes · NCT07549841

• IL-1β blocker after pancreatic transplant to help prevent graft thrombosis

  This trial tests whether adding Anakinra right after pancreatic transplant is safe for patients to see if it helps protect the new pancreas.

  Recruiting Phase 1/2 Nantes University Hospital · Nantes and 1 other locations · NCT07503834

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.